NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Chunghwa Chemical Synthesis & Biotech Co. Ltd (TW: 1762)

 
1762 Technical Analysis
5
As on 9th Jun 2023 1762 STOCK Price closed @ 92.80 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 58.25 & Strong Buy for SHORT-TERM with Stoploss of 63.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

1762STOCK Price

Open 88.80 Change Price %
High 93.70 1 Day 5.10 5.82
Low 88.50 1 Week 4.00 4.50
Close 92.80 1 Month 1.00 1.09
Volume 2678861 1 Year 26.90 40.82
52 Week High 102.50 | 52 Week Low 49.50
 
TW Taiwan Most Active Stocks
3231 73.00 7.35%
2888 8.96 -1.65%
1609 39.50 -2.47%
2618 35.85 -0.14%
2356 38.65 6.18%
2382 131.50 9.58%
2323 13.00 -1.89%
2303 52.30 1.55%
2353 34.20 1.33%
2630 61.40 4.42%
 
TW Taiwan Top Gainers Stocks
3043 41.25 10.00%
6668 43.60 9.96%
6668 43.60 9.96%
1419 46.35 9.96%
1419 46.35 9.96%
2705 25.00 9.89%
3515 201.00 9.84%
2376 240.50 9.82%
3054 23.55 9.79%
3383 1.70 9.68%
 
TW Taiwan Top Losers Stocks
6289 1.35 -10.00%
2482 67.50 -9.03%
1533 58.70 -6.38%
1533 58.70 -6.38%
6625 136.50 -5.86%
2731 181.00 -5.48%
2707 308.00 -4.94%
1612 26.75 -4.80%
1612 26.75 -4.80%
4155 35.30 -4.47%
 
 
1762
Daily Charts
1762
Intraday Charts
Whats New @
Bazaartrend
1762
Free Analysis
 
1762 Important Levels Intraday
RESISTANCE102.82
RESISTANCE99.61
RESISTANCE97.62
RESISTANCE95.63
SUPPORT89.97
SUPPORT87.98
SUPPORT85.99
SUPPORT82.78
 
1762 Forecast May 2024
4th UP Forecast107.06
3rd UP Forecast102.49
2nd UP Forecast99.66
1st UP Forecast96.83
1st DOWN Forecast88.77
2nd DOWN Forecast85.94
3rd DOWN Forecast83.11
4th DOWN Forecast78.54
 
1762 Weekly Forecast
4th UP Forecast101.47
3rd UP Forecast98.69
2nd UP Forecast96.97
1st UP Forecast95.25
1st DOWN Forecast90.35
2nd DOWN Forecast88.63
3rd DOWN Forecast86.91
4th DOWN Forecast84.13
 
1762 Forecast2024
4th UP Forecast195.12
3rd UP Forecast162.31
2nd UP Forecast142.02
1st UP Forecast121.74
1st DOWN Forecast63.86
2nd DOWN Forecast43.58
3rd DOWN Forecast23.29
4th DOWN Forecast-9.52
 
 
1762 Other Details
Segment EQ
Market Capital 5080180224.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
1762 Address
1762
 
1762 Latest News
 
Your Comments and Response on Chunghwa Chemical Synthesis & Biotech Co. Ltd
 
1762 Business Profile
Chunghwa Chemical Synthesis & Biotech Co. Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, pain management, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. In addition, it is developing renal dialysis and gastrointestinal drugs. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co. Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan. Address: No.1, Dongxing Street, New Taipei City, Taiwan, 23850
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service